Press Releases
-
·The world first cell culture-based influenza vaccine, ‘SKYCellflu™’ is approved ...2023.02.02 -
- SK bioscience shared a development history of the South Korea’s first COVID-19 vaccine at the Riya...2023.01.27 -
- Two biopharmaceutical experts join SK bioscience to strengthen the future strategies - With recru...2023.01.20 -
-The world-second developed shingles vaccine ‘SKYZoster™’ is approved by the National Pharmaceutic...2023.01.09 -
SK bioscience received A+ in Social and A in Environment and Governance categories in the first ESG ...2022.11.25 -
SK bioscience and IVI had a conference to discuss a cooperation against the next pandemic SK de...2022.11.17 -
SK bioscience explained the company’s sustainable growth strategy at investors meeting SK...2022.11.01 -
SK bioscience, a global innovative vaccine and biotech company committed to promoting human ...2022.10.27 -
-CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; ...2022.10.25 -
- Global experts continue to join SK bioscience, while its U.S. corporate entity is being esta...2022.10.21 -
Company submitted an application for CMA of SKYCovione™ to MHRA and EMA, followed by EUL to WHO. ...2022.09.08 -
· 609,000 doses of advance purchased SKYCovione™ will be sequentially supplied based on...2022.09.02